Robert T. Bailer

1986–2025 年に発表

別表記
Robert T Bailer
99
論文数
22,483
被引用数
84
h 指数
97
i10 指数

被引用数

Robert T. Bailer の年別被引用数1987 年: 被引用 1 件1988 年: 被引用 4 件1989 年: 被引用 4 件1990 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 7 件1993 年: 被引用 8 件1995 年: 被引用 3 件1998 年: 被引用 1 件1999 年: 被引用 2 件2000 年: 被引用 5 件2001 年: 被引用 16 件2002 年: 被引用 10 件2003 年: 被引用 12 件2004 年: 被引用 6 件2005 年: 被引用 7 件2006 年: 被引用 23 件2007 年: 被引用 35 件2008 年: 被引用 78 件2009 年: 被引用 34 件2010 年: 被引用 84 件2011 年: 被引用 87 件2012 年: 被引用 77 件2013 年: 被引用 166 件2014 年: 被引用 236 件2015 年: 被引用 362 件2016 年: 被引用 415 件2017 年: 被引用 460 件2018 年: 被引用 455 件2019 年: 被引用 1,222 件2020 年: 被引用 1,329 件2021 年: 被引用 1,050 件2022 年: 被引用 680 件2023 年: 被引用 493 件2024 年: 被引用 731 件2025 年: 被引用 355 件2026 年: 被引用 4 件1994 年は被引用が無いため表示していません1996〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,761 件、この内訳の 38.7%イギリス: 引用元論文 493 件、この内訳の 6.9%中国: 引用元論文 356 件、この内訳の 5%ドイツ: 引用元論文 276 件、この内訳の 3.9%オランダ: 引用元論文 267 件、この内訳の 3.7%フランス: 引用元論文 227 件、この内訳の 3.2%南アフリカ: 引用元論文 205 件、この内訳の 2.9%カナダ: 引用元論文 204 件、この内訳の 2.9%オーストラリア: 引用元論文 184 件、この内訳の 2.6%スイス: 引用元論文 175 件、この内訳の 2.4%イタリア: 引用元論文 148 件、この内訳の 2.1%インド: 引用元論文 122 件、この内訳の 1.7%
0%38.7%その他 24%

分野

  • Medicine48.3%
  • Immunology and Microbiology38.6%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Agricultural and Biological Sciences0.6%
  • Environmental Science0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • その他1.6%

トピック

  • HIV Research and Treatment12%
  • SARS-CoV-2 and COVID-19 Research5.6%
  • Immune Cell Function and Interaction5.6%
  • Monoclonal and Polyclonal Antibodies Research5.4%
  • vaccines and immunoinformatics approaches4.2%
  • Immunotherapy and Immune Responses3.9%
  • その他63.3%

共著者

全論文

検索で開く
  1. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kwanyee Leung, Wing‐Pui Kong, Alec W. Freyn, Raffael Nachbagauer, Peter Palese, Robert T. Bailer, Adrian B. McDermott, Richard A. Koup, Jason G. Gall, Frank Arnold, John R. Mascola, Barney S. Graham, Julie E. Ledgerwood, the VRC 316 Study Team, Joseph P. Casazza, LaSonji A. Holman, Abidemi O. Ola, Pamela Costner, Jennifer Cunningham, Brenda Larkin, Laura Novik, Jamie Saunders, William Whalen, Xiaolin Wang, Aba Mensima Eshun, Alison Taylor, K.-C. Cheng, Carolyn M. Laurençot, Josephine H. Cox, Sandra Sitar, Lam Le, Iris Pittman, Olga Vasilenko, Ro Shauna Rothwell, Galina V. Yamshchikov, Eugenia Burch, Somia P. Hickman, Olga Trofymenko, Catina Boyd, Preeti Apte, Cora Trelles Cartagena, Renunda Hicks, Pernell Williams, Zana Blaku, Colin Tran - Nature Medicine 2022 被引用: 163

  2. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

    著者: , , , , , , , , , , , - Journal of Immunological Methods 2013 被引用: 585

  3. Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Seaman, Lawrence Shapiro, John R. Mascola, Peter D. Kwong, Mark Connors - Immunity 2016 被引用: 395

  4. Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barney S. Graham, Susan Moir, Richard A. Koup, John R. Mascola, James A. Hoxie, Anthony S. Fauci, Pablo Tebas, Tae‐Wook Chun - New England Journal of Medicine 2016 被引用: 475

  5. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip W. Berman, Nicole Frahm, Stephen C. De Rosa, Michael D. Alpert, Nicole L. Yates, Xiaoying Shen, Richard A. Koup, Punnee Pitisuttithum, Jaranit Kaewkungwal, Sorachai Nitayaphan, Supachai Rerks‐Ngarm, Nelson L. Michael, Jérôme H. Kim - New England Journal of Medicine 2012 被引用: 1,834

  6. Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yaroslav Tsybovsky, Ulrich Baxa, James C. Mullikin, Kanta Subbarao, Daniel C. Douek, Barney S. Graham, Richard A. Koup, Julie E. Ledgerwood, Mario Roederer, Lawrence Shapiro, Peter D. Kwong, John R. Mascola, Adrian B. McDermott - Cell 2016 被引用: 359

  7. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    著者: , , , , , , , , , , , , , , , , , , , - Nature 2012 被引用: 852

  8. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martha Sedegah, Awalludin Sutamihardja, Gary A. Fahle, Kirsten E. Lyke, Matthew B. Laurens, Mario Roederer, Kavita Tewari, Judith E. Epstein, B. Kim Lee Sim, Julie E. Ledgerwood, Barney S. Graham, Stephen L. Hoffman, the VRC 312 Study Team, Cassandra DiGiovanni, Pernell Williams, Nicole Luongo, Jillian Mitchell, Maria Burgos Florez, Brenda Larkin, Nina M. Berkowitz, Brandon Wilson, Tanya Clarke, Olga Vasilenko, Galina V. Yamshchikov, Sandra Sitar, LaChonne Stanford, Iris Pittman, Robert T. Bailer, Joseph P. Casazza, Hope DeCederfelt, Judith Starling, Esther C. Williams, Anna F. Lau, Stella Antonara, Jeffery Brocious, Margaret A. Kemp, James Inglese, Patricia Dranchak, Esteban Abot, Sharina Reyes, Harini Ganeshan, María Belmonte, Jun Huang, Arnel Belmonte, Jack Komisar, Yonas Abebe, Yeab Getachew, Asha Patil, Steve Matheny, K. E. Nelson, James Overby, Virak Pich, Yingda Wen, Richard Fan, Enni Fomumbod, Aderonke Awe, Chinnamma Chakiath, Mary D. King, Maria Socorro Orozco, Tooba Murshedkar, Debbie Padilla, Bing Jiang, Lixin Gao, Natasha KC, Rui Xu, Matthew Adams, Christopher V. Plowe, Hayley Loblein, Phyllis Renehan, Meghan Kunchai ほか 1 名 - Science 2013 被引用: 784

  9. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yongping Yang, Zhenhai Zhang, NISC Comparative Sequencing, James C. Mullikin, James Μ. Binley, Rogier W. Sanders, Ian A. Wilson, John P. Moore, Andrew C. Ward, George Georgiou, Carolyn Williamson, Salim S. Abdool Karim, Lynn Morris, Peter D. Kwong, Lawrence Shapiro, John R. Mascola - Nature 2014 被引用: 756

  10. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2018 被引用: 253

  11. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Stuckey, Paul V. Thomas, Tishina Tittley, Constance Williams, Baoshan Zhang, Hong Zhao, Zhou Zhou, Bruce R. Donald, Lawrence K. Lee, Susan Zolla‐Pazner, Ulrich Baxa, Arne Schön, Ernesto Freire, Lawrence Shapiro, Kelly K. Lee, James Arthos, James B. Munro, Scott C. Blanchard, Walther Mothes, James Μ. Binley, Adrian B. McDermott, John R. Mascola, Peter D. Kwong - Nature Structural & Molecular Biology 2015 被引用: 368

  12. Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Virology 2013 被引用: 363

  13. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Koup, Daniel C. Douek, Zonghui Hu, Edmund V. Capparelli, Barney S. Graham, John R. Mascola, Julie E. Ledgerwood, VRC 601 Study Team - Science Translational Medicine 2015 被引用: 479

  14. Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature, Nat. 2014 被引用: 779

  15. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yen‐Ting Lai, Thomas Lemmin, Krisha McKee, Tiffany Y. Ohr, Li Ou, Dongjun Peng, Ariana P. Rowshan, Zizhang Sheng, John-Paul Todd, Yaroslav Tsybovsky, Elise G. Viox, Yiran Wang, Hui Wei, Yongping Yang, Amy F. Zhou, Rui Chen, Lu Yang, Diana G. Scorpio, Adrian B. McDermott, Lawrence Shapiro, Bridget Carragher, Clinton S. Potter, John R. Mascola, Peter D. Kwong - Nature Medicine 2018 被引用: 310

  16. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hung‐Pin Peng, An‐Suei Yang, James C. Mullikin, Matthew D. Gray, Leonidas Stamatatos, Dennis R. Burton, Wayne C. Koff, Myron S. Cohen, Barton F. Haynes, Joseph P. Casazza, Mark Connors, Davide Corti, Antonio Lanzavecchia, Quentin J. Sattentau, Robin A. Weiss, Anthony P. West, Pamela J. Björkman, Johannes F. Scheid, Michel C. Nussenzweig, Lawrence Shapiro, John R. Mascola, Peter D. Kwong - Cell 2015 被引用: 340

  17. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynn Morris, John R. Mascola - Journal of Virology 2015 被引用: 261

  18. Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David C. Montefiori, Ashley M. Trama, Hua‐Xin Liao, Thomas B. Kepler, M. Anthony Moody, Feng Gao, Samuel J. Danishefsky, John R. Mascola, George M. Shaw, Beatrice H. Hahn, Stephen C. Harrison, Bette Korber, Barton F. Haynes - Science Translational Medicine 2017 被引用: 290

  19. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Connors, Andrew B. Ward, Peter D. Kwong, John R. Mascola - Science 2016 被引用: 377

  20. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barney S. Graham, Theodore C. Pierson, Julie E. Ledgerwood, Grace Chen, Sarah H. Plummer, Pamela Costner, Kathryn L. Zephir, Joseph P. Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham, Olga Vasilenko, Maria Burgos Florez, Somia P. Hickman, Iris Pittman, Lam Le, Brenda Larkin, Charla Andrews, Preeti Apte, Renunda Hicks, Cora Trelles Cartagena, Pernell Williams, Catina Boyd, Michelle Conan-Cibotti, Judy Stein, Florence Kaltovich, Hope DeCederfelt, Stacey McAdams, Phyllis Renehan, Wilbur Chen, Nancy Greenberg, Nancy Wymer, Linda Wadsworth, Melissa Billington, Toni Robinson, Colleen Boyce, Faith Pa'ahana Brown, Lisa Chrisley, Alyson Kwon, Prashant Patel, Panagoita Kominou, Brenda Dorsey, Staci Eddington, Shinyi Telscher, Myoughee Lee, Regina Mosely, April Ross, Geoffrey Ford, Briyana Domjahn, Jianguo Xu, Allison Beck, Rebecca Fineman, Shiela Heeke, Jean M. Winter, Shashi Nagar, Colleen F. Kelley, Mark J. Mulligan, Sarah H. Plummer, Pamela Costner, Kathryn L. Zephir, Joseph P. Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham ほか 18 名 - The Lancet 2017 被引用: 304

  21. Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James C. Mullikin, Lawrence Shapiro, Richard A. Koup, Barney S. Graham, Martha Nason, Mark Connors, Barton F. Haynes, Srinivas S. Rao, Mario Roederer, Peter D. Kwong, John R. Mascola, Gary J. Nabel - Journal of Virology 2014 被引用: 291

  22. Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brenna J. Hill, Rui Kong, Cinque Soto, James C. Mullikin, Daniel C. Douek, David C. Montefiori, Michael A. Moody, George M. Shaw, Beatrice H. Hahn, Garnett Kelsoe, Peter Hraber, Bette Korber, Scott D. Boyd, Andrew Fire, Thomas B. Kepler, Lawrence Shapiro, Andrew B. Ward, John R. Mascola, Hua‐Xin Liao, Peter D. Kwong, Barton F. Haynes - Cell 2016 被引用: 341

  23. Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lily Zhang, Yunda Huang, Richard A. Koup, Edmund V. Capparelli, Barney S. Graham, John R. Mascola, Julie E. Ledgerwood, Floreliz Mendoza, Laura Novik, Kathy Zephir, William Whalen, Brenda Larkin, Jamie Saunders, Jennifer Cunningham, Carol Levinson, Xiaolin Wang, Sarah H. Plummer, Milalynn Victorino, Abidemi Ola, Catina Boyd, Nilusha Jayasinghe, Preeti Apte, Cora Trelles Cartagena, Renunda Hicks, Pernell Williams, Olga Vasilenko, Galina V. Yamshchikov, Maria Burgos Florez, Iris Pittman, Lúcio Gama, Joseph P. Casazza, Hope DeCederfelt, KC Cheng, Judy Stein - The Lancet HIV 2019 被引用: 107

  24. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mario Roederer, Mark Connors, Richard A. Koup, Peter D. Kwong, Zhiyong Yang, John R. Mascola, Gary J. Nabel - Science 2017 被引用: 271